I believe we are almost there
Everything is coming to a head
Viraleze partnerships
Dep licensing deals with upfront payments
Major partner on board to distribute Vivagel into Europe and Asia with upfront signing fees
We will have 34 million in bank based solely on current burn rate and no income at December quarter
The share price does not reflect our current situation
I have upgraded my position from a hold to buy
Looking forward to Dep Docetaxel + Gemcitabine combination results
Should be outstanding
Catalysts and/or inflection points
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
